Ethicon Announces Agreement to Acquire Torax Medical, Inc.
CINCINNATI, Ohio –
February 17, 2017 – Ethicon, Inc. today announced
a definitive agreement to acquire Torax Medical, Inc., a privately held
medical device company that manufactures and markets the LINX® Reflux
Management System, a novel minimally invasive device for the surgical
treatment of GERD. The acquisition of Torax Medical will enable Ethicon to
offer patients a safe and effective alternative to the anatomy-altering
laparoscopic Nissen fundoplication surgical procedure. 1
This LINX ® Reflux Management System is a small implant comprised of
interlinked titanium beads with magnetic cores which augment the body’s
natural barrier function to prevent reflux. LINX is currently used by
physicians in over 300 hospitals in the United States and Europe. This
acquisition is consistent with Ethicon’s strategy of advancing innovation
and investing in areas of unmet medical needs such as esophageal health.
Financial terms of the transaction have not been disclosed. The closing of
the transaction is subject to clearance under the Hart-Scott-Rodino
Antitrust Improvements Act and other customary closing conditions. The
transaction is expected to close during the first quarter of 2017.
From creating the first sutures, to revolutionizing surgery with
minimally invasive procedures, Ethicon, part of the Johnson & Johnson
Medical Devices Companies, has made significant contributions to surgery for
more than 60 years. Our continuing dedication to Shape the Future of Surgery
is built on our commitment to help address the world’s most pressing health
care issues, and improve and save more lives. Through Ethicon’s surgical
technologies and solutions including sutures, staplers, energy devices,
trocars and hemostats and our commitment to treat serious medical conditions
like obesity and cancer worldwide, we deliver innovation to make a
life-changing impact. Learn more at
and follow us on Twitter @Ethicon.